Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q3 2022 Earnings Call Transcript November 14, 2022
Acumen Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.26 EPS, expectations were $-0.23.
Operator: Good day. Thank you for standing by. Welcome to the Acumen Pharmaceuticals, Q3 2022 Conference Call and Webcast. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there’ll be a question-and-answer session Please be advised that...
